Seborrheic dermatitis (SD). Seborrhoeic dermatitis
Conditions
Interventions
Intervention 1: Topical pimecrolimus cream 1% will be given to the 30 patients. They will be recommended to use tip finger amount of cream to each involved area, 2 times daily for 4 weeks. The Patient
Treatment - Drugs
Topical pimecrolimus cream 1% will be given to the 30 patients. They will be recommended to use tip finger amount of cream to each involved area, 2 times daily for 4 weeks. The Patients will be visite
Topical sertaconazole cream 2% will be given to the 30 patients. They will be recommended to use tip finger amount of cream to each involved area, 2 times daily for 4 weeks. The Patients will be visit
Sponsors
Vice-chancellor for research -Semnan University of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: facial seborrheic dermatitis; any systemic disease. exclusion criteria: taking drugs such as methyldopa, chlorpromazine, cimetidine; use of local and systemic anti-acne ,steroid and immune modulators drugs one month before; lactation and pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvment. Timepoint: 2 and 4 weeksafter starting treatment. Method of measurement: dermatologist examination.;Exacerbation. Timepoint: 1 month after stoping treatment. Method of measurement: dermatologist examination.;Treatment duration. Timepoint: 4 weeks. Method of measurement: time.;Patient satisfaction. Timepoint: 2 and 4 weeks after starting treatment. Method of measurement: question of patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effect. Timepoint: 2 and 4 weeks after starting treatment. Method of measurement: dermatologist examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Azizzadeh
Semnan University of Medical Science
Outcome results
None listed